No Data
China Resources Sanjiu Medical & Pharmaceutical Negotiates Inclusion of Two Products in Medical Insurance Catalog
China Resources Sanjiu Medical & Pharmaceutical (000999.SZ): The company's products and those of its subsidiaries have been included in the national medical insurance catalog for the first time through negotiations.
According to the announcement by China Resources Sanjiu Medical & Pharmaceutical (000999.SZ) on November 28, the company's pharmaceutical products Wenjing Tang granules and the pharmaceutical injection Cefuroxime Sodium of its wholly-owned subsidiary Zhejiang China Resources Jiuzhong Medical Pharmaceutical Co., Ltd. were included in the "National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug List (2024)" for the first time through negotiation, based on the notice issued by the National Medical Insurance Administration and the Ministry of Human Resources and Social Security on the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2024)" (referred to as the "2024 Drug List").
Tasly Pharmaceutical Group: Some products are priced down, leading to a decrease in Q3 gross margin. All parties are actively promoting the trade with China Resources Sanjiu Medical & Pharmaceutical | Straight to the earnings conference
① Due to the overall low prosperity in the pharmaceutical commerce industry, the company's revenue in this sector declined in the third quarter of this year; although revenue in the pharmaceutical industry sector grew year-on-year, the price reduction of some products led to a decrease in gross margin, and the company expects that the gross margin may remain stable in the future. ② Regarding the equity trade matter of the company's major shareholder with china resources sanjiu medical & pharmaceutical, the company's general manager Cai Jinyong stated that the company and relevant parties are actively promoting the various aspects of this trade.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Looks Interesting, And It's About To Pay A Dividend
China Resources Sanjiu Medical & Pharmaceutical (000999.SZ) plans to distribute 10 yuan for every 10 shares, with the ex-dividend date on November 29.
China Resources Sanjiu Medical & Pharmaceutical (000999.SZ) announced that the proposed equity distribution for the first three quarters of 2024 is: to all shareholders, each...
chinares pharma (03320): china resources sanjiu medical & pharmaceutical (000999.SZ) will sell 51% of its stake in Kunshan Pharmaceutical (600422.SH).
Chinares pharma (03320) issued an announcement that on November 21, 2024, china resources sanjiu medical & pharmaceutical and Kunming Pharma entered into a share transfer agreement...
China Resources Sanjiu Medical & Pharmaceutical's (SZSE:000999) Investors Will Be Pleased With Their Strong 123% Return Over the Last Three Years
